192 related articles for article (PubMed ID: 9855637)
1. Mibefradil inhibition of T-type calcium channels in cerebellar purkinje neurons.
McDonough SI; Bean BP
Mol Pharmacol; 1998 Dec; 54(6):1080-7. PubMed ID: 9855637
[TBL] [Abstract][Full Text] [Related]
2. Mibefradil (Ro 40-5967) blocks multiple types of voltage-gated calcium channels in cultured rat spinal motoneurones.
Viana F; Van den Bosch L; Missiaen L; Vandenberghe W; Droogmans G; Nilius B; Robberecht W
Cell Calcium; 1997 Oct; 22(4):299-311. PubMed ID: 9481480
[TBL] [Abstract][Full Text] [Related]
3. Voltage-dependent blockade of diverse types of voltage-gated Ca2+ channels expressed in Xenopus oocytes by the Ca2+ channel antagonist mibefradil (Ro 40-5967).
Bezprozvanny I; Tsien RW
Mol Pharmacol; 1995 Sep; 48(3):540-9. PubMed ID: 7565636
[TBL] [Abstract][Full Text] [Related]
4. Effect of mibefradil on voltage-dependent gating and kinetics of T-type Ca(2+) channels in cortisol-secreting cells.
Gomora JC; Xu L; Enyeart JA; Enyeart JJ
J Pharmacol Exp Ther; 2000 Jan; 292(1):96-103. PubMed ID: 10604935
[TBL] [Abstract][Full Text] [Related]
5. Mechanism of voltage- and use-dependent block of class A Ca2+ channels by mibefradil.
Aczél S; Kurka B; Hering S
Br J Pharmacol; 1998 Oct; 125(3):447-54. PubMed ID: 9806326
[TBL] [Abstract][Full Text] [Related]
6. Inhibition by mibefradil, a novel calcium channel antagonist, of Ca(2+)- and volume-activated Cl- channels in macrovascular endothelial cells.
Nilius B; Prenen J; Kamouchi M; Viana F; Voets T; Droogmans G
Br J Pharmacol; 1997 Jun; 121(3):547-55. PubMed ID: 9179399
[TBL] [Abstract][Full Text] [Related]
7. Contrasting biophysical and pharmacological properties of T-type and R-type calcium channels.
Randall AD; Tsien RW
Neuropharmacology; 1997 Jul; 36(7):879-93. PubMed ID: 9257934
[TBL] [Abstract][Full Text] [Related]
8. State-dependent inhibition of inactivation-deficient Ca(V)1.2 and Ca(V)2.3 channels by mibefradil.
Bernatchez G; Sauvé R; Parent L
J Membr Biol; 2001 Nov; 184(2):143-59. PubMed ID: 11719851
[TBL] [Abstract][Full Text] [Related]
9. T- and L-type Ca2+-channel antagonists reduce contractility in guinea pig cardiac myocytes.
Hoischen S; Brixius K; Schwinger RH
J Cardiovasc Pharmacol; 1998 Aug; 32(2):323-30. PubMed ID: 9700997
[TBL] [Abstract][Full Text] [Related]
10. Inhibitory action of mibefradil on calcium signaling and aldosterone synthesis in bovine adrenal glomerulosa cells.
Rossier MF; Ertel EA; Vallotton MB; Capponi AM
J Pharmacol Exp Ther; 1998 Dec; 287(3):824-31. PubMed ID: 9864260
[TBL] [Abstract][Full Text] [Related]
11. Mibefradil, A T-type calcium channel antagonist in Y1 cells.
Esneu M; Gallo-Payet N; Payet MD
Endocr Res; 1998; 24(3-4):449-54. PubMed ID: 9888524
[TBL] [Abstract][Full Text] [Related]
12. Mibefradil prevents neointima formation after vascular injury in rats. Possible role of the blockade of the T-type voltage-operated calcium channel.
Schmitt R; Clozel JP; Iberg N; Bühler FR
Arterioscler Thromb Vasc Biol; 1995 Aug; 15(8):1161-5. PubMed ID: 7627710
[TBL] [Abstract][Full Text] [Related]
13. Interaction of Ro 40-5967 and verapamil with the stably expressed alpha 1-subunit of the cardiac L-type calcium channel.
Lacinová L; Welling A; Bosse E; Ruth P; Flockerzi V; Hofmann F
J Pharmacol Exp Ther; 1995 Jul; 274(1):54-63. PubMed ID: 7616442
[TBL] [Abstract][Full Text] [Related]
14. Cardiovascular T-type calcium channels: physiological and pharmacological significance.
Triggle DJ
J Hypertens Suppl; 1997 Dec; 15(5):S9-15. PubMed ID: 9481611
[TBL] [Abstract][Full Text] [Related]
15. The Ca(++)-channel blocker Ro 40-5967 blocks differently T-type and L-type Ca++ channels.
Mehrke G; Zong XG; Flockerzi V; Hofmann F
J Pharmacol Exp Ther; 1994 Dec; 271(3):1483-8. PubMed ID: 7996461
[TBL] [Abstract][Full Text] [Related]
16. Effects of mibefradil, a blocker of T-type Ca2+ channels, in single myocytes and intact muscle of guinea-pig heart.
Emanuel K; Mackiewicz U; Pytkowski B; Lewartowski B
J Physiol Pharmacol; 1998 Dec; 49(4):577-90. PubMed ID: 10069698
[TBL] [Abstract][Full Text] [Related]
17. Cloning and characterization of alpha1H from human heart, a member of the T-type Ca2+ channel gene family.
Cribbs LL; Lee JH; Yang J; Satin J; Zhang Y; Daud A; Barclay J; Williamson MP; Fox M; Rees M; Perez-Reyes E
Circ Res; 1998 Jul; 83(1):103-9. PubMed ID: 9670923
[TBL] [Abstract][Full Text] [Related]
18. Comparative effects of mibefradil and other calcium antagonists on resistance arteries of different end organs.
van der Lee R; Pfaffendorf M; van Zwieten PA
Fundam Clin Pharmacol; 1999; 13(2):198-203. PubMed ID: 10226764
[TBL] [Abstract][Full Text] [Related]
19. [Blocking of T-type calcium channels: new horizons in the therapeutic potential of calcium antagonists].
Cerqueira-Gomes M; Maciel MJ; Martins L
Rev Port Cardiol; 1998 Jan; 17(1):9-15. PubMed ID: 9558949
[No Abstract] [Full Text] [Related]
20. Potential-dependent inhibition of cardiac Ca2+ inward currents by Ro 40-5967 and verapamil: relation to negative inotropy.
Fang LM; Osterrieder W
Eur J Pharmacol; 1991 Apr; 196(2):205-7. PubMed ID: 1651875
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
